Abstract
Abstract INTRODUCTION Radiation has a significant role in the management of pediatric brain tumors. Secondary complications to irradiation can include vascular malformations such as cavernous malformations, brain atrophy, necrosis, and demyelination. Although recognized as a potential complication, the pathogenesis and natural history of radiation induced cavernous malformations continues to be defined. We present a retrospective, single institution study of 138 patients who underwent cerebral radiotherapy as part of their comprehensive pediatric brain tumor management. METHODS Institutional review board permission was obtained and a retrospective review of all available patients with a pediatric brain tumor at our institution was completed. Patients who underwent radiotherapy and developed cavernous malformations were selected and the initial tumor type, frequency, and the radiological as well as clinical history were recorded and analyzed. RESULTS >From 1980–2005, 134 patients received radiotherapy for a pediatric brain tumor. Of this cohort, 28 patients (21%) subsequently developed at least one cerebral cavernous malformation. 21 of the patients had multiple cavernomas while only 7 were solitary. 15 patients were male. The mean time until discovery was 13.5 years. The tumor biology included 14 gliomas, 9 medulloblastomas, and 1 ependymoma. 14 patients received chemotherapy and all received at least short term corticosteroids. One patient required surgical excision of a cavernous malformation for repeated symptomatic hemorrhages. CONCLUSION Cavernous malformations are a frequent long term sequalae of pediatric radiotherapy. Although common, they are rarely associated with neurological complications even decades later and are largely discovered asymptomatically during routine surveillance screening of their primary disease. Future research in our database will be focused on establishing the relationship of radiation dose, age at irradiation, localization of radiotherapy, chemotherapy, anti-epileptics, and other medications on radiation induced cavernous malformations with the hope of identifying modifiable risk factors for clinical decision making application in a prospective fashion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.